一种新的抗CD47抗体,对NK/T细胞淋巴瘤具有治疗潜力
Liping Qin1,2, Yajun Li1, Ruolan Zeng1
1Department of Lymphoma and Hematology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.
Human vaccines & immunotherapeutics
|September 30, 2024
概括
用单克隆抗体AK117向CD47显示出治疗晚期NK/T细胞淋巴瘤 (NKTCL) 的前景. 这种免疫治疗方法增强了巨细胞化,并在临床前模型中抑制瘤生长,为NKTCL患者提供了潜在的新策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 血液学 血液学 血液学
背景情况:
- NK/T细胞淋巴瘤 (NKTCL) 是一种罕见的非霍奇金淋巴瘤,在晚期或耐火阶段的预后不佳.
- CD47是癌症免疫治疗的潜在标,但其在NKTCL中的作用和抗CD47疗法的疗效尚不清楚.
研究的目的:
- 为了研究NKTCL细胞中的CD47表达.
- 评估NKTCL中抗CD47单克隆抗体 (mAb) AK117的治疗潜力.
主要方法:
- 用免疫块和流动细胞计量分析了CD47表达.
- 使用shRNA进行了CD47敲击,以评估其对NKTCL细胞增殖,细胞亡和细胞周期的影响.
- 在SCID小鼠中使用M2巨细胞的体外细胞分析和体内异种移植模型来评估AK117的疗效.
主要成果:
- 发现CD47在NKTCL细胞中表达高.
- 用抗CD47 mAb AK117降低CD47和治疗促进了NKTCL细胞M2巨细胞化在体外.
- 在临床前的NKTCL异种移植模型中,AK117显著抑制了瘤生长.
结论:
- CD47是NKTCL的一个有前途的治疗点.
- 抗CD47单克隆抗体,如AK117,代表了NKTCL的潜在免疫疗法策略.
相关概念视频
01:27Cytotoxic T Cells-mediated Immune Response
857
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
857
01:27Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K